Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

An account that goes by the handle "Walter Bloomberg" shared a snippet that reportedly came from National Economic Council ...

Needham hosted an expert to discuss potential impact of trade tariffs and personnel changes on healthcare equities. Generic ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.

After CMS excluded a Biden administration proposal for CMS to cover anti-obesity medications proposal from the final contract year 2026 ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

The White House Wednesday listed tariff rates for different countries. It didn’t take long for market observers to try and reverse engineer the formula.

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Eli Lilly is escalating its legal push to protect the exclusivity ... images, photos, graphics, graphs, charts, animations, ...

Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...

U.S. stock futures slipped on Monday night as the market awaited clarity from President Donald Trump regarding his tariff ...